DNA Script raised €34M in a Series B round in Apr 2019. The company is based in Paris, France. Investors in the round: Bpifrance, Life Sciences Partners. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
